As you know, the coronavirus crisis has dealt a heavy blow to our cancer patient community. Life saving treatments are being postponed left and right, and those with depleted immune systems are forced to take extra precautions to stay healthy, resulting in even more isolation than usual.
In our effort to continue to advocate for the cancer community during these difficult times, we have started to monitor all cancer clinical trials that are being suspended due to COVID-19.
We completely understand the difficult decisions that oncologists and trial facilitators are being forced to make when suspending these trials. This is simply meant to serve as a resource for patients who are and need to become empowered to take ownership of their cancer journey.
We will always be here to ensure cancer treatment remains a top priority. We must not forget that cancer is still the second leading cause of death. We must continue to push for the innovation needed to fight this horrible disease. Our lives depend on it!
Of all clinical trials suspended due to COVID-19, cancer trials make up 30%!
We will do everything in our power to keep a spotlight on this disruption in life saving cancer treatment until the cancer research industry is back on its feet and thriving.
You can stay up to date on all info related to cancer and COVID-19 in our portal Fight Corona AND Cancer.
Please let us know if there are other ways we can support you during this difficult time.
Tzvia – TrialJectory, CEO, co-founder, cancer patient.
P.S. If you haven’t taken our quick survey about how COVID-19 is impacting your treatment, please do here.